医学临床研究
醫學臨床研究
의학림상연구
JOURNAL OF CLINICAL RESEARCH
2013年
7期
1404-1406
,共3页
冯晓辉%邓晓雯%李湘胜%王继华%肖旭平
馮曉輝%鄧曉雯%李湘勝%王繼華%肖旭平
풍효휘%산효문%리상성%왕계화%초욱평
睡眠呼吸暂停 ,阻塞性/血液%内皮缩血管肽1/血液
睡眠呼吸暫停 ,阻塞性/血液%內皮縮血管肽1/血液
수면호흡잠정 ,조새성/혈액%내피축혈관태1/혈액
Sleep Apnea,Obstructive/BL%Endothelin-1/BL
[目的]探讨人Ⅱ型肺泡细胞表面抗原(KL-6)、ET-1在阻塞性睡眠呼吸暂停低通气综合征(OSAHS)患者血清中的水平及意义。[方法]根据嗜睡量表、睡眠呼吸监测(PSG)选取75例鼾症患者,将其分为非OSAHS组、轻中度OSAHS组、重度OSAHS组三组,每组各25例,采用酶联免疫分析技术(ELISA)测定各组患者治疗干预前外周血清KL-6与ET-1水平。[结果]①血清KL-6、ET-1在非OSAHS组对象和轻中度OSAHS组血清水平差异均无统计学意义( P >0.05);重度OSAHS组患者中的水平明显高于轻中度OSAHS组和非OSAHS组( P <0.05)。②血清KL-6、ET-1水平与OSAHS病情严重程度有关( P <0.05),与患者性别、年龄无关( P >0.05)。③OSAHS患者血清中KL-6、ET-1水平呈正相关(r=0.942,P <0.05)。[结论]重度OSAHS患者出现亚临床血管内皮细胞损伤,与疾病严重程度相关,与患者性别、年龄无关;重度OSAHS患者并发心血管并发症的风险性明显高于轻中度OSA HS患者及非OSA HS患者。
[目的]探討人Ⅱ型肺泡細胞錶麵抗原(KL-6)、ET-1在阻塞性睡眠呼吸暫停低通氣綜閤徵(OSAHS)患者血清中的水平及意義。[方法]根據嗜睡量錶、睡眠呼吸鑑測(PSG)選取75例鼾癥患者,將其分為非OSAHS組、輕中度OSAHS組、重度OSAHS組三組,每組各25例,採用酶聯免疫分析技術(ELISA)測定各組患者治療榦預前外週血清KL-6與ET-1水平。[結果]①血清KL-6、ET-1在非OSAHS組對象和輕中度OSAHS組血清水平差異均無統計學意義( P >0.05);重度OSAHS組患者中的水平明顯高于輕中度OSAHS組和非OSAHS組( P <0.05)。②血清KL-6、ET-1水平與OSAHS病情嚴重程度有關( P <0.05),與患者性彆、年齡無關( P >0.05)。③OSAHS患者血清中KL-6、ET-1水平呈正相關(r=0.942,P <0.05)。[結論]重度OSAHS患者齣現亞臨床血管內皮細胞損傷,與疾病嚴重程度相關,與患者性彆、年齡無關;重度OSAHS患者併髮心血管併髮癥的風險性明顯高于輕中度OSA HS患者及非OSA HS患者。
[목적]탐토인Ⅱ형폐포세포표면항원(KL-6)、ET-1재조새성수면호흡잠정저통기종합정(OSAHS)환자혈청중적수평급의의。[방법]근거기수량표、수면호흡감측(PSG)선취75례한증환자,장기분위비OSAHS조、경중도OSAHS조、중도OSAHS조삼조,매조각25례,채용매련면역분석기술(ELISA)측정각조환자치료간예전외주혈청KL-6여ET-1수평。[결과]①혈청KL-6、ET-1재비OSAHS조대상화경중도OSAHS조혈청수평차이균무통계학의의( P >0.05);중도OSAHS조환자중적수평명현고우경중도OSAHS조화비OSAHS조( P <0.05)。②혈청KL-6、ET-1수평여OSAHS병정엄중정도유관( P <0.05),여환자성별、년령무관( P >0.05)。③OSAHS환자혈청중KL-6、ET-1수평정정상관(r=0.942,P <0.05)。[결론]중도OSAHS환자출현아림상혈관내피세포손상,여질병엄중정도상관,여환자성별、년령무관;중도OSAHS환자병발심혈관병발증적풍험성명현고우경중도OSA HS환자급비OSA HS환자。
[Objective]To explore the serum KL-6 and ET-1 levels in patients with obstructive sleep apnea hypopnea syndrome(OSAHS ) and the significance .[Methods]According to drowsiness scale and sleep respiratory monitoring (PSG) ,75 adult patients were chosen and divided into non-OSAHS group ,mild to moderate OSAHS group and severe OSAHS group with 25 cases in each group .ELISA was used to examine serum levels of KL-6 and ET-1 in each group be-fore intervention therapy .[Results] There was no significant difference in serum levels of KL-6 and ET-1 between non-OSAHS group and mild to moderate OSAHS group ( P>0 .05) ,but those in severe OSAHS group were obviously higher than those in mild to moderate OSAHS group and non-OSAHS group( P<0 .05) .Serum levels of KL-6 and ET-1 were related to the severity of OSAHS( P<0 .05) ,but not related to the gender and age of patients( P>0 .05) .There was positive linear correlation between serum KL-6 and ET-1(r=0 .942 ,P <0 .05) .[Conclusion]Severe OSAHS patients have sub-clinical vascular endothelial cell(VEC) injury ,which is related to the severity of OSAHS ,but not related to the gender and age of patients .The risk of cardiovascular complications in severe OSAHS patients is obviously higher than that in mild to moderate OSA HS patients and non-OSA HS patients .